DISCOUNT CALL-OPTIONSSCHEIN - BAYER | Market Closed - Deutsche Boerse AG 20:50:15 07/06/2024 BST | ||
| 0.008 EUR | -11.11% |
|
| 3 months | -60.00% | ||
| 6 months | -87.69% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BAYER AG
| Date | Price | Change |
|---|---|---|
| 07/06/24 | 0.008 | -11.11% |
| 06/06/24 | 0.009 | -18.18% |
| 05/06/24 | 0.011 | +10.00% |
| 04/06/24 | 0.01 | 0.00% |
| 03/06/24 | 0.01 | +25.00% |
Delayed Quote Deutsche Boerse AG
Last update June 07, 2024 at 08:50 pm
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BAYER AG |
| Issuer | 
BNP Paribas
|
| WKN | PE95NU |
| ISIN | DE000PE95NU6 |
| Date issued | 02/03/2023 |
| Strike | 65 € |
| Maturity | 20/12/2024 (196 Days) |
| Parity | 1 : 1 |
| Emission price | 1.53 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.06 € |
|---|---|
| Lowest since issue | 0.001 € |
Company Profile
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows:
- agrochemicals (48.8%): herbicides, fungicides, insecticides, etc.;
- pharmaceutical products (38%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.;
- OTC products and nutritional supplements (12.7%);
- other (0.5%).
Net sales are distributed geographically as follows: Germany (5.1%), Switzerland (1.2%), Europe-Middle East-Africa (23.2%), the United States (30.6%), North America (3.5%), China (7.6%), Asia-Pacific (10%), Brazil (10.4%) and Latin America (8.4%).
Sector
-
Consensus: Bayer AG
Sell
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
28.09
EUR
Average target price
36.18
EUR
Spread / Average Target
+28.81%
- Stock Market
- Certificates
- Certificat
